![Peter Stephen Keen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Stephen Keen
Direttore/Membro del Consiglio presso
Lifearc
Profilo
Peter Stephen Keen is the founder of Excalibur Fund Managers Ltd. (1996), Ark Therapeutics Group Plc (1997), and Chiroscience Group Plc (1992).
He is currently a Director at Endomagnetics Ltd., a Director at SpringWorks Therapeutics LLC, and a Trustee at Lifearc.
Mr. Keen's former positions include Chief Executive Officer at Cambridge Innovation Capital Ltd (2013-2015), Chairman at Oval Medical Technologies Ltd., Director at Vectura Group Ltd., Director at ReNeuron Group Plc, Senior Independent Non-Executive Director at Abcam Plc (2010-2014), Director at Prelude Trust Plc (2007-2009), Independent Non-Executive Director at The Biotech Growth Trust Plc (2013-2017), Board Member & Finance Director at Serentis Ltd. (2010), Director at Exosect Ltd., Non-Executive Director at Horizon Discovery Ltd., Director at Cyclacel Ltd., Non-Executive Director at Congenica Ltd., Independent Non-Executive Director at HealthCare Royalty Trust PLC, Chief Financial Officer at BioProgress Plc, Principal at The MicroBio Group Ltd., Chief Financial Officer at Sosei R&D Ltd. (2004-2006), Partner at Molten Ventures (Private Equity) (2006-2007), and Member-Supervisory Board at Kiadis Pharma BV.
Keen received an undergraduate degree from The University of Hull.
Posizioni attive di Peter Stephen Keen
| Società | Posizione | Inizio |
|---|---|---|
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Operates as a life science medical research charity company | Direttore/Membro del Consiglio | 01/02/2013 |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company that develops oncology medicines | Direttore/Membro del Consiglio | - |
Endomagnetics Ltd.
 Endomagnetics Ltd. Packaged SoftwareTechnology Services Develops breast cancer surgery technology | Direttore/Membro del Consiglio | 23/02/2017 |
Precedenti posizioni note di Peter Stephen Keen
| Società | Posizione | Fine |
|---|---|---|
| THE BIOTECH GROWTH TRUST PLC | Direttore/Membro del Consiglio | 12/07/2017 |
| ABCAM PLC | Direttore/Membro del Consiglio | 03/11/2014 |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Discovers and develops medicinal gene-based and biological therapies and diagnostic products | Fondatore | 12/03/2012 |
Serentis Ltd.
 Serentis Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and distributes pharmaceutical products | Direttore Finanziario/CFO | 01/03/2010 |
Prelude Trust Plc
 Prelude Trust Plc Investment ManagersFinance Acts as Venture Capital Fund | Direttore/Membro del Consiglio | 18/06/2009 |
Formazione di Peter Stephen Keen
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
66
Relazioni di 1° grado
25
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 25 |
|---|---|
BioProgress Plc
 BioProgress Plc Miscellaneous Commercial ServicesCommercial Services Develops medicines and healthcare products using polymer technologies | Commercial Services |
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures inhalation drugs and medical devices | Health Technology |
ReNeuron Group Plc
 ReNeuron Group Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and manufactures cell-based therapy products | Health Technology |
Abcam Plc
 Abcam Plc BiotechnologyHealth Technology Produces and distributes research-grade antibodies and associated products | Health Technology |
Prelude Trust Plc
Prelude Trust Plc Investment ManagersFinance Acts as Venture Capital Fund | Finance |
The Biotech Growth Trust Plc
 The Biotech Growth Trust Plc Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
The MicroBio Group Ltd.
 The MicroBio Group Ltd. Chemicals: AgriculturalProcess Industries Manufactures organic fertilizers and crop protection products | Process Industries |
Excalibur Fund Managers Ltd.
 Excalibur Fund Managers Ltd. Investment ManagersFinance Excalibur invests in companies located in the United Kingdom. The firm targets companies operating in the fields of biotechnology and medical devices. It provide financing for mezzanine, seed, early and later stage capital requirements. | Finance |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Discovers and develops medicinal gene-based and biological therapies and diagnostic products | Commercial Services |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Chiroscience Group Plc
 Chiroscience Group Plc Miscellaneous Commercial ServicesCommercial Services Research based pharmaceutical group | Commercial Services |
The University of Hull
 The University of Hull Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lifearc
Lifearc Miscellaneous Commercial ServicesCommercial Services Operates as a life science medical research charity company | Commercial Services |
Molten Ventures (Private Equity)
 Molten Ventures (Private Equity) Investment ManagersFinance Esprit Capital Partners invests in companies located in Europe with valuation from USD 50m-1 billion. The firm focuses on companies operating in the fields of consumer technology, digital Health & wellness, Ai, deeptech & hardware, cloud and enterprise & Saas. It provides financing for early, growth and secondary capital requirements. It also makes fund of funds and follow on investments. | Finance |
Kiadis Pharma BV
 Kiadis Pharma BV Pharmaceuticals: MajorHealth Technology Operates as a is a clinical stage biopharmaceutical company focused on research, development and future commercialization of cell based immunotherapy products | Health Technology |
Serentis Ltd.
Serentis Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and distributes pharmaceutical products | Health Technology |
Exosect Ltd.
 Exosect Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and provides pest management solutions | Commercial Services |
Horizon Discovery Ltd.
 Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and supplying patient-relevant drug discovery and diagnostic research tools | Commercial Services |
Cyclacel Ltd. | |
Oval Medical Technologies Ltd.
 Oval Medical Technologies Ltd. Medical SpecialtiesHealth Technology Manufactures drug delivery devices focusing on vials, prefilled syringes and autoinjectors | Health Technology |
Endomagnetics Ltd.
Endomagnetics Ltd. Packaged SoftwareTechnology Services Develops breast cancer surgery technology | Technology Services |
Congenica Ltd.
 Congenica Ltd. Packaged SoftwareTechnology Services Operates as a digital health company that enables analysis of genomic data | Technology Services |
Cambridge Innovation Capital Ltd
 Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital seeks investment opportunities in companies located in the United Kingdom. The firm focuses on technology and life science companies. It participates in seed, early and late stage capital transactions. The firm makes co-investments. | Finance |
HealthCare Royalty Trust PLC
 HealthCare Royalty Trust PLC Investment Trusts/Mutual FundsMiscellaneous Operates as a closed-ended investment fund | Miscellaneous |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company that develops oncology medicines | Health Technology |
